Artificial intelligence is quickly becoming a game‑changer in eye medicine. Researchers are exploring how powerful language models—like the latest versions of ChatGPT—can help doctors diagnose and treat eye diseases faster and more accurately. Early experiments show that AI can read complex eye scans, spot early signs of conditions such as macular degeneration, and even suggest treatment options. Studies also highlight the promise of AI‑driven chat tools that answer patients’ questions, streamline appointment scheduling, and assist clinicians with up‑to‑date research. While the technology shows great potential, experts caution that AI still has limits, especially when it comes to nuanced clinical judgment and patient safety. Ongoing trials are testing how well these systems perform in real‑world clinics, aiming to balance innovation with rigorous oversight. In short, generative AI is poised to augment ophthalmologists’ work—making eye exams quicker, improving disease detection, and offering new ways for patients to engage with their eye health—while researchers continue to fine‑tune its accuracy and reliability.
Read more